Cancer Prevention Studies
The York Cancer Center strives to bring the most current cancer therapies
available to our community, with respect to treatment, symptom management, and
prevention. We continue to collaborate in a large number of National
Cancer Institute and industry-sanctioned cooperative group trials. These
collaborations have allowed us the opportunity to help bring some cancer
treatments to our community that would normally be available only at larger
centers or universities.
Our research team continually works to provide the community with a variety of
prevention studies. The research team is a dedicated group of
professionals who work in conjunction with physicians, nurses and patients to
facilitate enrollment in studies and detail collection of research data, which
is then submitted to the statistical centers.
The following is a list of
the cancer prevention studies that are currently available to our patients in
the community.
To learn more about prevention studies, talk to your physician or call us at
(717) 741-8100 or (877) 441-7957.
(S0000A) PREADVISE - Ancillary study of SELECTProstatePrimary objective is to define the affect of selenium and vitamin E in combination in the reduction of the incidence of Alzheimer's Disease (AD)as determined by mental status screening and clinical evaluation, in a population of men age 62 or older (60 if African-American or Hispanic) participating in SELECT.
Record Created: 2006-04-03 17:22:39
|
(S0000B) SEE - Ancillary study of SELECTProstatePrimary objectives are to test whether 400 mg of vitamin E and/or 200 mcg of selenium reduce the risk of visually significant Age-related Macular Degeneration &/or cataract risk.
Record Created: 2006-04-03 17:22:50
|
|
